Trevena Announces Publication and Presentations of OLINVO™ (oliceridine injection) Clinical Data
Trevena, Inc. (TRVN)
Last trevena, inc. earnings: 3/12 07:01 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.trevena.com/investor-relations
Company Research
Source: GlobeNewswire
– American Society of Anesthesiologists Annual Meeting presentations highlight OLINVO data from positive Phase 3 trials – – OLINVO Phase 2b data published in Journal of Pain Research – CHESTERBROOK, Pa., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it presented two posters describing the results of APOLLO-1 and APOLLO-2, the Company’s two successful Phase 3 pivotal efficacy studies of OLINVO, at the 2017 Annual Meeting of the American Society of Anesthesiologists (ASA) held in Boston from October 21-25, 2017. The Company also announced that results of its Phase 2b trial of Breakthrough Therapy-designated OLINVO (oliceridine injection) have been published in the peer-reviewed Journal of Pain Research. “I’m pleased to see continued peer-reviewed publication and presentation of our head to head comparisons of OLINVO to IV morphine,” said Maxine Gowen, Ph.D., chief executive officer. “We know physicians and hospitals want to understand how a n
Show less
Read more
Impact Snapshot
Event Time:
TRVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRVN alerts
High impacting Trevena, Inc. news events
Weekly update
A roundup of the hottest topics
TRVN
News
- Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Trevena, Inc. (NASDAQ: TRVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.MarketBeat
- Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
TRVN
Earnings
- 8/14/23 - Miss
TRVN
Analyst Actions
- 4/2/24 - HC Wainwright
TRVN
Sec Filings
- 4/22/24 - Form 8-K
- 4/19/24 - Form PRE
- 4/9/24 - Form 8-K
- TRVN's page on the SEC website